INNO

InnoCan Pharma Corporation

  • Canada
  • Consumer
  • Consumer Staples
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.12
FY22:
2.11
FY23:
–
FY24:
26.2
FY25:
23.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.48
FY22:
−6.27
FY23:
–
FY24:
−1.25
FY25:
−1.26
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.44
FY22:
−6.21
FY23:
–
FY24:
−1.21
FY25:
−1.21
(positive)
Change from FY21 to FY25
millions USD
FY21:
−10.1
FY22:
−3.89
FY23:
–
FY24:
0.92
FY25:
0.09
(positive)
Change from FY21 to FY25
millions USD
FY21:
−10.0
FY22:
−3.76
FY23:
–
FY24:
−1.83
FY25:
−1.12

All amounts in millions USD Data source:Twelve Data